M. Umair Mushtaq, MD

Professional Background

Dr. Muhammad Umair Mushtaq is an Assistant Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center. He completed a Hematology and Oncology fellowship at the University of Wisconsin Hospitals and Clinics. He earned his medical degree from Allama Iqbal Medical College and completed his residency at Cook County Health and Hospitals System.

• MBBS, Medicine and Surgery, Allama Iqbal Medical College (Lahore, Pakistan), Lahore, Punjab
• Residency, Internal Medicine, Cook County Health and Hospitals System, Chicago, IL
• Clinical Fellowship, Hematology & Oncology, University of Wisconsin Hospital and Clinics, Madison, WI

• Kansas Medical License , Kansas State Board of Healing Arts
• Missouri Medical License , Missouri Division of Professional Registration
• Physician License (MD), Medicine and Surgery, Wisconsin State Medical Examining Board

• American Society for Transplantation and Cellular Therapy, Member, 2019 - Present
• American Society of Hematology, Member, 2017 - Present
• American Society of Clinical Oncology, Member, 2015 - Present
• American College of Physicians, Member, 2014 - Present
• American College of Physicians, Member, 2008 - 2011

---

Research

Overview

Dr. Mushtaq is a clinical investigator with a focus on hematologic malignancies, hematopoietic stem cell transplantation, cellular therapy, immunotherapy, and global health. He has a long history of research productivity with over 1000 citations.

• Impact of Microbiota on outcomes after chimeric antigen receptor (CAR) T-cell therapy, HMCT Division, Internal Funding, Site-PI
• Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion before Tumor-Infiltrating Lymphocytes Therapy with Lifileucel in Metastatic Melanoma, Iovance Biotherapeutics, Inc., PI
• A Phase lb, Open-Label, Randomized, Dose-Finding, Multicenter Study To Evaluate The Safety, Efficacy, And Pharmacokinetics Of GDC-8264 In Combination With Standard Of Care In The Treatment Of Acute Graft-Versus-Host Disease In Patients Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (GA43861), Genentech, Inc., Site-PI

• Mushtaq Muhammad Umair, Shahzad Moazzam, Chaudhary Sibgha Gull, Luder Mary, Ahmed Nausheen, Abdelhakim Haitham, Bansal Rajat, Balusu Ramesh, DeJarnette Shaun, Divine Clint, Kribs Robert, Shune Leyla, Singh Anurag K, Ganguly Siddhartha, Abhyankar Sunil H, McGuirk Joseph P. 2021. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.. Transplantation and Cellular Therapy, 27 (9), 796.e1-796.e7
• Shahzad M, Hussain A, Tariq E, Anwar I, Faisal MS, Syed L, Karam A, Chaudhary SG, Ahmed N, Bansal R, Khurana S, Singh AK, Byrd KP, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU. 2023. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis.. Clinical lymphoma, myeloma & leukemia, 23 (3), 178-187
• Siddiqui Raheel Sufian, Chaudhary Sibgha Gull, Shahzad Moazzam, Anwar Iqra, Hussain Ali, Ahmed Nausheen, Abhyankar Sunil Hari, Shune Leyla, Hematti Peiman, Male Heather, Khosa Faisal, Lin Tara, McGuirk Joseph P, Callander Natalie Scott, Mushtaq Muhammad Umair. 2022. Gender Disparities in the National Institutes of Health Funding for Hematologic Malignancies and Cellular Therapies. Leukemia & lymphoma, 1-6
• Shahzad Moazzam, Chaudhary Sibgha Gull, Zafar Muhammad Umair, Hassan Maha A, Hussain Ali, Ali Fatima, Anwar Iqra, Ahmed Mamoon, Ahmed Nausheen, Khurana Sharad, Rauf Muhammad A, Anwar Faiz, Hematti Peiman, Callander Natalie S, Abhyankar Sunil H, McGuirk Joseph P, Mushtaq Muhammad Umair. 2022. Impact of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis. Transplant infectious disease : an official journal of the Transplantation Society, e13792
• Shahzad Moazzam, Chaudhary Sibgha Gull, Tariq Ezza, Mushtaq Ali, Anwar Iqra, Ahmed Nausheen, Bansal Rajat, Lutfi Forat, Ramesh Balusu, Abdelhakim Haitham, Yacoub Abdulraheem, Hematti Peiman, Singh Anurag, McGuirk Joseph, Mushtaq Muhammad Umair. 2022. Use of Endpoints in Phase III Randomized Controlled Trials for Acute Myeloid Leukemia over the Last 15 Years: A Systematic Review Journal. Leukemia and Lymphoma
• Khanam R., Shahzad M., Chaudhary S. G, Ali F., Shah Z., Pachika P. S, Ahmed Z., Chattaraj A., Masood A., Ahmed N., Bansal R., Balusu R., Shune L., Anwar F., Hematti P., McGuirk J. P, Yacoub A., Mushtaq M. U. 2022. Outcomes After Venetoclax With Hypomethylating Agents in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis. Leukemia & lymphoma, 1-8
• Mushtaq MU, Shahzad M, Tariq E, Iqbal Q, Chaudhary SG, Zafar MU, Anwar I, Ahmed N, Bansal R, Singh AK, Abhyankar SH, Callander NS, Hematti P, McGuirk JP. 2022. Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis.. Frontiers in oncology, 12, 1005042
• Shahzad Moazzam, Anwar Iqra, Siddiqui Raheel Suflan, Ahmed Tehniat Faraz, Majeed Mahrukh, Hassan Maha Awaiz, Ahmed Zahoor, Neupan Karun, Ali Tayyaba, Faisal Muhammad Salman, Naseem Masooma, Chaudhary Sibgha Gull, Balusu Ramesh, Ahmed Nausheed, Singh Anurag K, Abhyankar Sunil H, McGuirk Joseph P, Anwer Faiz, Mushtaq Muhammad Umair. 2021. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.. Transplantation and cellular therapy, 27 (10), 877.e1-877.e8
• Mushtaq M. U, Harrington A. M, Chaudhary S. G, Michaelis L. C, Carlson K. B, Abedin S., Runass L., Callander N. S, Fallon M. J, Juckett M., Hall A. C, Hematti P., Mattison R. J, Atallah E. L, Guru Murthy G. S. 2020. Comparison of Salvage Chemotherapy Regimens and Prognostic Significance of Minimal Residual Disease in Relapsed/Refractory Acute Myeloid Leukemia. Leukemia & Lymphoma, 1-9
• Mushtaq Muhammad Umair, Papadas Anthanasios, Pagenkopf Adam, Flietner Evan, Morrow Zachary, Chaudhary Sibgha Gull, Asimakopoulos Fotis. 2018. Tumor Matrix Remodeling and Novel Immunotherapies: The Promise of Matrix-Derived Immune Biomarkers. Journal for immunotherapy of cancer, 6 (1), 65